Found: 48
Select item for more details and to access through your institution.
Phase II study of the c-MET inhibitor tivantinib (ARQ 197) in patients with relapsed or relapsed/refractory multiple myeloma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Severe peripheral neuropathy following carfilzomib, rituximab, and dexamethasone for initial treatment of Waldenström's macroglobulinemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Single‐agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1571, doi. 10.1002/ajh.27029
- By:
- Publication type:
- Article
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi‐institutional experience.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. E276, doi. 10.1002/ajh.26580
- By:
- Publication type:
- Article
Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity‐score matched analysis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. E455, doi. 10.1002/ajh.26360
- By:
- Publication type:
- Article
A phase I/II trial of the combination of lenalidomide, thalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 12, p. E319, doi. 10.1002/ajh.25633
- By:
- Publication type:
- Article
Long‐term durable efficacy of autologous stem cell transplantation in POEMS syndrome.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. E72, doi. 10.1002/ajh.25375
- By:
- Publication type:
- Article
Melphalan‐based autologous transplant in octogenarian multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. E2, doi. 10.1002/ajh.25310
- By:
- Publication type:
- Article
Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma.
- Published in:
- American Journal of Hematology, 2012, v. 87, n. 3, p. 272, doi. 10.1002/ajh.22273
- By:
- Publication type:
- Article
Curability of Multiple Myeloma.
- Published in:
- Bone Marrow Research, 2012, p. 1, doi. 10.1155/2012/916479
- By:
- Publication type:
- Article
Current Treatment Strategies for Multiple Myeloma.
- Published in:
- Clinical Lymphoma & Myeloma, 2007, v. 7, p. S139
- By:
- Publication type:
- Article
Hepatitis B Virus Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 8, p. 610, doi. 10.1016/j.clml.2023.04.006
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions: Waldenström Macroglobulinemia - 2021 Update on Management and Future Directions.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 6, p. 347, doi. 10.1016/j.clml.2021.11.014
- By:
- Publication type:
- Article
P-197: Central nervous system Multiple Myeloma (CNS-MM), presentation and outcomes in an Era of anti-CD38 and pomalidomide inclusive therapies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S146, doi. 10.1016/S2152-2650(21)02324-7
- By:
- Publication type:
- Article
Waldenström Macroglobulinemia - 2020 Update on Management and Future Directions.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Minimal Residual Disease Negativity Does Not Overcome Poor Prognosis in High-Risk Multiple Myeloma: A Single-Center Retrospective Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Postoperative Radiotherapy for Multiple Myeloma of Long Bones: Should the Entire Rod Be Treated?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Acalabrutinib in Patients (pts) with Waldenström Macroglobulinemia (WM).
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2018, v. 18, p. S285, doi. 10.1016/j.clml.2018.07.222
- By:
- Publication type:
- Article
Randomized Phase II Trial of Combination Idiotype Vaccine and Anti-CD3/Anti-CD28 Costimulated Autologous T Cells in Patients with Multiple Myeloma Post-Autotransplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e138, doi. 10.1016/j.clml.2017.03.250
- By:
- Publication type:
- Article
A Case Control Study of Syngeneic Transplantation Versus Autologous Transplantation for Multiple Myeloma: Two Decades of Experience at MD Anderson.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. e8, doi. 10.1016/j.clml.2017.03.014
- By:
- Publication type:
- Article
Outcome of Patients With Nonsecretory Multiple Myeloma After Autologous Hematopoietic Stem Cell Transplantation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
- By:
- Publication type:
- Article
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
- By:
- Publication type:
- Article
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00973-w
- By:
- Publication type:
- Article
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
- By:
- Publication type:
- Article
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
- By:
- Publication type:
- Article
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 3, p. 357, doi. 10.1111/bjh.12266
- By:
- Publication type:
- Article
Blockade of interleukin-6 signalling with siltuximab enhances melphalan cytotoxicity in preclinical models of multiple myeloma.
- Published in:
- British Journal of Haematology, 2011, v. 152, n. 5, p. 579, doi. 10.1111/j.1365-2141.2010.08533.x
- By:
- Publication type:
- Article
Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvement.
- Published in:
- European Journal of Haematology, 2016, v. 97, n. 4, p. 342, doi. 10.1111/ejh.12736
- By:
- Publication type:
- Article
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1663, doi. 10.1002/cncr.35171
- By:
- Publication type:
- Article
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1944, doi. 10.1111/bjh.19384
- By:
- Publication type:
- Article
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up‐front autologous stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 866, doi. 10.1111/bjh.18944
- By:
- Publication type:
- Article
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 4, p. e37, doi. 10.1111/bjh.18753
- By:
- Publication type:
- Article
Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide‐based maintenance therapy.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. e23, doi. 10.1111/bjh.17393
- By:
- Publication type:
- Article
Gene expression profiling predicts relapse‐free and overall survival in newly diagnosed myeloma patients treated with novel therapies.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 4, p. e115, doi. 10.1111/bjh.17344
- By:
- Publication type:
- Article
Survival Disparities Between African American and Caucasian Patients With Multiple Myeloma Are Blunted in the Era of Novel Therapeutics and Autologous Stem Cell Transplantation.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. E31, doi. 10.3816/CLML.2010.n.041
- By:
- Publication type:
- Article
Solitary plasmacytomas.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 19, p. 4468, doi. 10.1002/cncr.26031
- By:
- Publication type:
- Article
Personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma: a non-randomized phase 1 trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-50880-2
- By:
- Publication type:
- Article
Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone.
- Published in:
- Journal of Molecular Medicine, 2012, v. 90, n. 6, p. 695, doi. 10.1007/s00109-011-0849-9
- By:
- Publication type:
- Article
Evaluation of the QTc prolongation potential of a monoclonal antibody, siltuximab, in patients with monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or low-volume multiple myeloma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 1, p. 35, doi. 10.1007/s00280-013-2314-7
- By:
- Publication type:
- Article
Subclinical pretreatment sensory deficits appear to predict the development of pain and numbness in patients with multiple myeloma undergoing chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2013, v. 71, n. 6, p. 1531, doi. 10.1007/s00280-013-2152-7
- By:
- Publication type:
- Article
Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis.
- Published in:
- Journal of Hematology & Oncology, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13045-015-0172-y
- By:
- Publication type:
- Article
Electroacupuncture for thalidomide/bortezomib-induced peripheral neuropathy in multiple myeloma: a feasibility study.
- Published in:
- Journal of Hematology & Oncology, 2014, v. 7, n. 1, p. 1, doi. 10.1186/1756-8722-7-41
- By:
- Publication type:
- Article
Validation of the M. D. Anderson Symptom Inventory multiple myeloma module.
- Published in:
- Journal of Hematology & Oncology, 2013, v. 6, n. 1, p. 1, doi. 10.1186/1756-8722-6-13
- By:
- Publication type:
- Article